KRRO — Korro Bio, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1703647 ·
Last close
$12.32
Market Cap
$169.10M
52W High
$17.35
52W Low
$5.20
ADV30
215,321
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -18,456,000 -17,548,000 148,120,000 40,215,000 59,746,000
Jun 2026 0 — -20,110,000 -18,916,000 163,446,000 24,905,000 60,220,000
Mar 2026 0 — -20,436,000 -19,625,000 183,622,000 61,697,000 63,989,000
Dec 2025 1,292,000 — -15,883,000 -50,042,000 113,506,000 21,824,000 62,067,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-63,705,000
Investing CF
$-6,965,000
Financing CF
$85,675,000
CapEx
$-169,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.66
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-439,935,000
Inventory
—
Receivables
$0
ST Investments
$64,779,000
EBIT TTM
$-74,885,000
Pretax Income TTM
$-105,032,000
Interest Exp TTM
—
Analysts
10

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,292,000
EBITDA
$-74,366,000
Free Cash Flow
$-43,673,000
Enterprise Value
$138,982,272
Total Cash
$104,994,000
Total Debt
$41,523,000
Shares Out
13,725,646
Trailing EPS
$-8.89
Book Value
$6.44
ROE
-113.3%
ROA
-30.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 6,392,000 -87,342,000 -117,260,000 113,506,000 62,067,000 51,439,000 -78,561,000
Dec 2024 2,271,000 -91,910,000 -83,581,000 226,240,000 65,825,000 160,415,000 -60,074,000
Dec 2023 0 -84,534,000 -81,172,000 221,663,000 51,752,000 169,911,000 -67,283,000
Dec 2022 0 -58,998,000 -58,032,000 73,742,000 172,773,000 -99,031,000 -53,645,000

TTM Snapshot

Revenues TTM
$2,382,000
NetIncome TTM
$-106,644,000
OpCashFlow TTM
—
Assets (Latest)
$163,446,000
Forward EPS
$-4.27

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $17.50 · spot: $12.44 · call volume: 16 · put volume: 23
Expected Move to 2026-12-18: ±$5.00 (40.19%) — implied range $7.44 – $17.44 · ATM straddle on $12.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IFRX InflaRx N.V. $169.47M $1.15 —
ORMP ORAMED PHARMACEUTICALS INC. $168.29M $3.87 —
ELDN Eledon Pharmaceuticals, Inc. $167.23M $1.98 —
PYXS Pyxis Oncology, Inc. $172.24M $1.44 —
SLGL Sol-Gel Technologies Ltd. $172.97M $52.83 —

News headlines (Yahoo Finance, 1h cache)

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-11-13 21:05 · Yahoo
Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
2026-11-06 12:00 · Yahoo
Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-05 12:00 · Yahoo
Korro Bio, Inc. (KRRO) Surges 29.7%: Is This an Indication of Further Gains?
2026-10-23 09:47 · Yahoo
Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency
2026-10-22 11:00 · Yahoo
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-16 20:05 · Yahoo
Korro to Participate in Upcoming Investor Conferences
2026-08-27 11:00 · Yahoo
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-08-06 11:00 · Yahoo
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock?
2026-07-08 16:00 · Yahoo
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock?
2026-06-19 12:06 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.